T3	Treatment 0 54	One week after the initial-dose of adalimumab (160 mg)
T5	Effect 149 173	fulminant cardiomyopathy
T8	Treat-Disorder 108 123	Crohn's disease
T9	Drug 35 45	adalimumab
T10	Dosage 47 53	160 mg
T6	Subject 83 136	an acute exacerbation of Crohn's disease, the patient
T4	Adverse_event 137 146	developed
E1	Adverse_event:T4 
T1	Time_elapsed 0 8	One week
